家禽用重组病毒疫苗的现状和未来。

Advances in veterinary medicine Pub Date : 1999-01-01 DOI:10.1016/s0065-3519(99)80038-x

M W Jackwood

{"title":"家禽用重组病毒疫苗的现状和未来。","authors":"M W Jackwood","doi":"10.1016/s0065-3519(99)80038-x","DOIUrl":null,"url":null,"abstract":"The use of biotechnology to create recombinant viral vaccines holds many promises for the future. But, to be practical, new vaccines must have a selective advantage over traditional vaccines. A vaccine that is novel because it is a recombinant vaccine is not enough. Recombinant vaccines must be safer, or more efficacious, or less expensive to produce in order for them to gain a niche in the marketplace.","PeriodicalId":72111,"journal":{"name":"Advances in veterinary medicine","volume":"41 ","pages":"517-22"},"PeriodicalIF":0.0000,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/s0065-3519(99)80038-x","citationCount":"19","resultStr":"{\"title\":\"Current and future recombinant viral vaccines for poultry.\",\"authors\":\"M W Jackwood\",\"doi\":\"10.1016/s0065-3519(99)80038-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The use of biotechnology to create recombinant viral vaccines holds many promises for the future. But, to be practical, new vaccines must have a selective advantage over traditional vaccines. A vaccine that is novel because it is a recombinant vaccine is not enough. Recombinant vaccines must be safer, or more efficacious, or less expensive to produce in order for them to gain a niche in the marketplace.\",\"PeriodicalId\":72111,\"journal\":{\"name\":\"Advances in veterinary medicine\",\"volume\":\"41 \",\"pages\":\"517-22\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/s0065-3519(99)80038-x\",\"citationCount\":\"19\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in veterinary medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s0065-3519(99)80038-x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in veterinary medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s0065-3519(99)80038-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 19

摘要

利用生物技术制造重组病毒疫苗为未来带来了许多希望。但是，为了实用，新疫苗必须比传统疫苗具有选择性优势。一种疫苗仅仅因为是重组疫苗而新颖是不够的。重组疫苗必须更安全，或更有效，或生产成本更低，才能在市场上获得一席之地。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Current and future recombinant viral vaccines for poultry.

The use of biotechnology to create recombinant viral vaccines holds many promises for the future. But, to be practical, new vaccines must have a selective advantage over traditional vaccines. A vaccine that is novel because it is a recombinant vaccine is not enough. Recombinant vaccines must be safer, or more efficacious, or less expensive to produce in order for them to gain a niche in the marketplace.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Advances in veterinary medicine

自引率

0.00%

发文量

期刊最新文献

In ovo vaccination technology. Evaluation of risks and benefits associated with vaccination against coronavirus infections in cats. Forty years of canine vaccination. Canine viral vaccines at a turning point--a personal perspective. Vaccines and diagnostic methods for bovine mastitis: fact and fiction.